发明授权
US06482834B2 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
失效
抑制血小板衍生生长因子和/或p56lck酪氨酸激酶的喹啉和喹喔啉化合物
- 专利标题： Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
- 专利标题（中）： 抑制血小板衍生生长因子和/或p56lck酪氨酸激酶的喹啉和喹喔啉化合物
-
申请号： US09828633申请日： 2001-04-06
-
公开(公告)号： US06482834B2公开(公告)日： 2002-11-19
- 发明人: Alfred P. Spada , Wei He , Michael R. Myers
- 申请人： Alfred P. Spada , Wei He , Michael R. Myers
- 主分类号： A61K3147
- IPC分类号： A61K3147
摘要：
This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
公开/授权文献
信息查询
